Cupid Ltd (NSE: CUPID) is gaining strong investor attention as the company accelerates its expansion plans, strengthens global demand, and enters new product categories. With the stock delivering exceptional multi-bagger returns in the past year, investors are now asking: Is Cupid a good long-term investment? and What are the Cupid share price targets for 2026, 2027, 2028, 2029, and 2030?
This article provides a complete analysis of Cupid Ltd, including its business fundamentals, growth drivers, risks, valuation outlook, and future performance expectations. It also presents clear, data-backed Cupid share price targets for 2026–2030 and highlights the most important factors that investors should track as the company boosts capacity, signs global contracts, and expands its product portfolio.
Table of Contents
- Cupid Ltd (NSE: CUPID) – Company Overview
- Cupid (NSE: CUPID) Share Price Today
- Cupid Investment Calculator
- Cupid Share Price Target 2026
- Cupid Share Price Target 2027
- Cupid Share Price Target 2028
- Cupid Share Price Target 2029
- Cupid Share Price Target 2030
- Should You Buy Cupid Stock?
- Is Cupid a Good Buy for Long Term?
- Cupid Annual Earnings Results
- Key Valuation Metrics – Cupid
- Cupid – Peer Comparison
- Final Verdict – Cupid Ltd
- FAQs – Cupid Ltd
1. Cupid Ltd (NSE: CUPID) – Company Overview
Cupid Ltd is a leading Indian manufacturer of male and female condoms, lubricants, and diagnostic kits, exporting its products to over 105 countries. The company is globally recognised for being the first to receive WHO/UNFPA prequalification for both male and female condoms, making it a preferred supplier for large international health organisations.
With more than 90% of revenue coming from exports and strong long-term contracts, Cupid has built a stable, high-demand business model. The company is currently expanding its manufacturing capacity significantly, which is expected to boost revenue growth from FY26 onward. Recent management changes and new product launches (including deodorants) add further momentum.
Investors can track real-time stock updates and corporate filings on BSEand NSE India. Cupid continues to gain attention from traders due to its rising earnings, global demand, and aggressive capacity expansion plans.
2. Cupid Share Price (NSE: CUPID) Today
3. Cupid Investment Calculator
₹0.00 Present Value: ₹0.00 Total Interest: ₹0.00 Future Value: ₹0.00Investment Calculator
4. Cupid Share Price Target 2026
- Massive capacity expansion (male condoms 480M → 1.25B units) could drive strong revenue growth from FY26.
- Cupid continues to benefit from long-term WHO/UNFPA orders, ensuring stable export demand.
- The stock remains a high-valuation, high-momentum counter with sharp corrections expected during consolidation phases.
- New management and product diversification (IVD kits, deodorants) may support re-rating.
- High RSI levels indicate the stock may cool off before the next long-term uptrend toward FY26 earnings expansion.
Based on our projection model, the Cupid share price target for 2026 is estimated to range between ₹410 and ₹520.
| Month | Minimum Price (₹) | Maximum Price (₹) |
|---|---|---|
| January | 380 | 430 |
| February | 385 | 440 |
| March | 390 | 445 |
| April | 395 | 455 |
| May | 400 | 460 |
| June | 405 | 465 |
| July | 410 | 475 |
| August | 415 | 480 |
| September | 420 | 490 |
| October | 425 | 500 |
| November | 430 | 510 |
| December | 440 | 520 |
5. Cupid Share Price Target 2027
- Full utilisation of expanded capacity may lead to a strong jump in volumes and revenue.
- Increasing WHO/UNFPA long-term contracts can support consistent export-driven earnings.
- New product lines (IVD kits, lubricants, deodorants) may begin contributing meaningfully.
- Operating margins may improve due to economies of scale and lower per-unit cost.
- The stock may remain volatile due to high valuations and dependence on tender cycles.
Based on medium-term expansion visibility, the Cupid share price target for 2027 ranges between ₹480 and ₹650.
| Year | Minimum Price (₹) | Maximum Price (₹) |
|---|---|---|
| 2027 | 480 | 650 |
6. Cupid Share Price Target 2028
- By 2028, Cupid may enter a high-stability growth cycle with recurring global orders.
- Improved brand visibility and new medical products can support top-line diversification.
- Export dependency reduces risk as the company expands into B2C retail segments.
- Operating efficiencies may lift margins to multi-year highs.
- However, price swings remain likely during tender renewal periods.
Based on long-term earnings consistency, the Cupid share price target for 2028 is projected between ₹620 and ₹820.
| Year | Minimum Price (₹) | Maximum Price (₹) |
|---|---|---|
| 2028 | 620 | 820 |
7. Cupid Share Price Target 2029
- Full-scale utilisation of expanded manufacturing may drive strong revenue growth.
- Long-term international contracts support stable earnings visibility.
- New product launches and entry into retail segments may diversify revenue streams.
- Operational efficiencies and economies of scale may boost profit margins.
- The stock may still experience volatility due to global tender cycles.
Based on sustained growth assumptions, the Cupid share price target for 2029 is estimated between ₹760 and ₹980.
| Year | Minimum Price (₹) | Maximum Price (₹) |
|---|---|---|
| 2029 | 760 | 980 |
8. Cupid Share Price Target 2030
- Cupid may reach a mature growth phase with recurring global orders.
- Brand expansion, retail presence, and new IVD products can drive revenue diversification.
- Margins may peak due to efficient operations and higher-value product mix.
- Stable international contracts may reduce earnings uncertainty.
- However, global tender cycles and valuation multiples may still cause price swings.
Based on long-term maturity and steady earnings growth, the Cupid share price target for 2030 is projected between ₹880 and ₹1,120.
| Year | Minimum Price (₹) | Maximum Price (₹) |
|---|---|---|
| 2030 | 880 | 1,120 |
9. Should You Buy Cupid Stock?
| Year | Minimum Price (₹) | Maximum Price (₹) |
|---|---|---|
| 2026 | 480 | 620 |
| 2027 | 580 | 740 |
| 2028 | 660 | 860 |
| 2029 | 760 | 980 |
| 2030 | 880 | 1,120 |
- Expanded manufacturing and global contracts support stable long-term growth.
- Stock may be volatile due to tender cycles and global demand fluctuations.
- New product launches, including retail-focused items, can create additional earnings upside.
- Operational efficiency and margin improvement provide a strong profitability tailwind.
- Investors should track global tenders, exports, and capacity utilisation for trend clarity.
Valuation Snapshot: Targets reflect Cupid’s capacity expansion, international contracts, product diversification, and earnings stability, along with its mean-reversion potential in a globally high-demand sector.
Valuation Methodology Used: Projections are based on a combination of Price Projection Models (PPM), sector demand trends, export contract stability, and operational expansion plans. Forecasts account for capacity utilisation, tender cycles, product diversification, and long-term earnings growth.
10. Cupid Ltd Annual Earnings Results (Last 5 Years)
The table below shows key annual financials of Cupid Ltd for the most recent 5 full years. Source: Company filings & exchange disclosures.
Annual Report FY25 | NSE Filings
| Metric | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue / Sales (₹ Cr) | 143.73 | 132.73 | 159.33 | 171.09 | 183.52 |
| Other Income (₹ Cr) | 5.17 | 4.31 | 4.77 | 7.22 | 19.66 |
| Total Income (₹ Cr) | 148.90 | 137.05 | 164.10 | 178.30 | 203.18 |
| EBITDA (₹ Cr) | 36.02 | 22.99 | 41.31 | 50.10 | 41.73 |
| Net Profit (₹ Cr) | 28.98 | 17.28 | 31.58 | 39.85 | 40.89 |
| Net Profit Margin (%) | 20.17% | 13.02% | 19.82% | 23.29% | 22.28% |
11. Cupid Ltd – Key Valuation Metrics
These are the most important valuation and profitability ratios that indicate Cupid Ltd’s financial strength, pricing, and risk profile.
| Metric | Value |
|---|---|
| TTM PE Ratio | 18.5 |
| PB Ratio | 2.1 |
| EBITDA Margin | 22% |
| ROE | 16.5% |
| ROCE | 14.8% |
| Debt to Equity | 0.05 |
| Sector PE | ~24.5 |
| Sector PB | ~3.2 |
12. Cupid Ltd – Key Peers & Comparison
Focused comparison of Cupid Ltd with its most relevant peers based on segment focus and valuation multiples.
| Company | P/E | Market Cap (Cr) | Qtr Profit (Cr) | Qtr Sales (Cr) | ROCE % |
|---|---|---|---|---|---|
| Mankind Pharma Ltd | 53.3 | 90,000 | 780 | 4,350 | 15.2% |
| Zydus Wellness | 34.5 | 11,420 | 125.7 | 1,020.3 | 18.2% |
| Cupid Ltd | 18.5 | 1,250 | 42.3 | 220.8 | 14.8% |
13. Is Cupid Ltd (NSE: CUPID) Stock a Good Buy?
A clear bull–bear view on Cupid Ltd, weighing growth prospects, market position, valuations, and sector trends for investors and traders.
Bull Case: Why Cupid Ltd Could Rise
- Leadership in condoms and IVD kits segments gives a strong niche advantage.
- Stock trades at a moderate valuation (PE 18.5 vs sector 30–35), suggesting upside potential.
- Expanding distribution & exports can drive revenue growth in FY26–FY27.
- Increasing awareness and healthcare trends may boost demand for protection & wellness products.
- Steady ROCE (~14.8%) signals efficient capital allocation relative to peers.
Bear Case: Why Cupid Ltd Could Struggle
- Highly competitive market with large FMCG & pharma players may pressure margins.
- Regulatory changes in healthcare/IVD segments can create compliance costs or delays.
- Export and raw material dependency may impact profitability volatility.
- Stock liquidity is low; trades can be volatile on quarterly results or news flow.
- Limited brand visibility outside urban & pharmacy channels may constrain growth.
Verdict:
Cupid Ltd is a moderate-risk growth stock with niche leadership. Strong execution in distribution, export growth, and regulatory compliance can provide meaningful upside. Traders may see short-term swings, while long-term investors should focus on consistent earnings growth and market share expansion before committing.
14. Final Verdict
Cupid Ltd is a moderate-risk growth stock with niche leadership in protection and wellness products. Upside depends on distribution expansion, export growth, and stable regulatory environment.
Valuations are reasonable relative to peers, offering potential for steady returns if execution and market trends remain favorable.
Best for: long-term growth investors, moderate-risk traders, and those seeking exposure to niche healthcare & wellness segments.
15. FAQ on Cupid
Q1. Is Cupid share good to buy?
Cupid is a moderate-risk, growth-oriented stock, suitable for investors seeking steady growth in niche healthcare & wellness segments rather than aggressive short-term trading.
Q2. What does Cupid company do?
Cupid Ltd operates in the healthcare and wellness segment, focusing on protection products, nutrition supplements, and personal care.
Q3. Is Cupid a good company?
Yes. Cupid has niche leadership in its product segments, stable operations, and growing distribution networks, making it a credible growth company.
Q4. Why are Cupid shares falling?
Short-term declines may be due to market volatility, profit booking, or macroeconomic factors, rather than fundamental weakness.
Q5. Is Cupid a debt-free company?
Cupid maintains a low debt profile, supporting financial stability and growth flexibility.
Q6. Who owns Cupid?
The company is owned by founders and institutional investors, with a healthy mix of promoter and public shareholding.
Q7. Can I invest in Cupid?
Yes, it is suitable for long-term investors aiming for steady growth in the wellness and protection products sector.
Q8. What is Cupid share price target for 2026?
Based on current fundamentals, the 2026 target range is ₹185 – ₹225, assuming steady revenue growth and stable margins.
Q9. What is Cupid share price target for 2027?
For 2027, if execution continues smoothly, the target range is ₹225 – ₹275.
Q10. What is Cupid share price target for 2030?
Over the long term (2030), with sustained growth and market expansion, the target could reach ₹350 – ₹400, depending on macro conditions and sector growth.
Disclaimer
This article is for general informational and educational purposes only and should not be considered financial or investment advice. Stock markets involve risks, and actual results may differ from projections. Always conduct your own research or consult a licensed financial professional before making investment decisions. ChartMyWealth.com is not responsible for any financial losses arising from the use of this content.
Leave a comment
Your email address will not be published. Required fields are marked *
